drugset / Trial / NCT04145375
Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
NaSingle-groupOpen-labelTreatment
Summary
Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
Timeline
- Start
- 2019-11-12
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZEN-3694 | Small molecule | 120 mg | — |
| Background | Enzalutamide | Other / unclassified | 160 mg | — |